Risk factors for long COVID among healthcare workers, Brazil, 2020–2022

Author:

Marra Alexandre R.ORCID,Sampaio Vanderson Souza,Ozahata Mina Cintho,da Silva Rafael Lopes Paixão,Brito Anderson,Bragatte Marcelo,Kalil Jorge,Miraglia João Luiz,Malheiros Daniel Tavares,Guozhang Yang,Teich Vanessa Damazio,Victor Elivane da Silva,Pinho João Renato Rebello,Cypriano Adriana,Vieira Laura Wanderly,Polonio Miria,de Oliveira Solange Miranda,Ricardo Victória Catharina Volpe,Maezato Aline Miho,Callado Gustavo Yano,Schettino Guilherme de Paula Pinto,de Oliveira Ketti Gleyzer,Santana Rúbia Anita Ferraz,Malta Fernanda de Mello,Amgarten Deyvid,Boechat Ana Laura,Kobayashi Takaaki,Perencevich Eli,Edmond Michael B.,Rizzo Luiz Vicente

Abstract

ABSTRACTObjectivesWe aimed to determine risk factors for the development of long coronavirus disease (COVID) in healthcare workers (HCWs).MethodsWe conducted a case-control study among HCWs who had confirmed COVID-19 infection working in a Brazilian healthcare system between March 1, 2020 and July 15, 2022. Cases were defined as those having long COVID per the Centers for Disease Control and Prevention definition. Controls were defined as HCWs who had documented COVID-19 infection but did not develop long COVID. Multiple logistic regression was used to assess the association between exposure variables and long COVID during 180 days of follow-up.ResultsOf 7,051 HCWs diagnosed with COVID-19 infection, 1,933 (27.4%) who developed long COVID were compared to 5,118 (72.6%) who did not. The majority of those with long COVID (51.8%) had 3 or more symptoms. Factors associated with development of long COVID were female sex (OR 1.21 [CI95 1.05-1.39]), age (OR 1.01 [CI95 1.00-1.02]), and two or more COVID-19 infections (1.27 [CI95 1.07-1.50]). Those infected with the Delta variant (OR 0.30 [CI95 0.17-0.50]) or the Omicron variant (OR 0.49 [CI95 0.30-0.78]), and those receiving four COVID-19 vaccine doses prior to infection (OR 0.05 [CI95 0.01-0.19]) were significantly less likely to develop long COVID.ConclusionsLong COVID can be prevalent among HCWs. We found that acquiring more than one COVID-19 infection was a major risk factor for long COVID, while maintenance of immunity via vaccination was highly protective.

Publisher

Cold Spring Harbor Laboratory

Reference38 articles.

1. Centers for Disease Control and Prevention (CDC). National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Long COVID or Post-COVID Conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed 05/20/2022.

2. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review;The Journal of infectious diseases,2022

3. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis;International journal of infectious diseases: IJID : official publication of the International Society for Infectious Diseases,2022

4. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Lancet (London, England),2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3